Muhammad Umair Mushtaq/X
Jun 15, 2025, 09:17
Muhammad Umair Mushtaq: Excited to Share that I’ve Been Selected as a Next Generation Scholar for the National Cancer Institute’s Blood and Marrow Transplant Clinical Trials Network
Muhammad Umair Mushtaq, Associate Professor Hematologic Malignancies & Cellular Therapeutics at KU Medical Center, shared a post on X:
“Excited to share that I’ve been selected as a Next Generation Scholar for the National Cancer Institute’s Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 2025-2026! Grateful for the opportunity and honored to contribute to this groundbreaking work in advancing cancer therapies.”
Stay updated with Hemostasis Today.
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis
-
Jun 23, 2026, 22:32How WFH Impacted the Bleeding Disorders Community in 2025
-
Jun 23, 2026, 18:27Advancing Gene Therapy Research for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Jun 23, 2026, 18:17What Every ITP Patient Wants to Know – ITP Support Association
-
Jun 23, 2026, 18:13Ahsan Fareed: Exploring Heart Failure Readmissions in Iron Deficiency Anemia
-
Jun 23, 2026, 18:09Swarnava Roy: Key Findings on Stress Erythropoiesis and Mitochondrial Retention in RBCs
-
Jun 23, 2026, 17:40Hossam El Benawi: How do We Predict Recurrence Post LVT Resoultion?
-
Jun 23, 2026, 17:39Nicolas Gendron: Do We Really Need All These Hemostasis Tests in Patients on DOACs?
-
Jun 23, 2026, 17:33Maité Mulkers: Time is Brain, and One Reason is That a Thrombus Develops Over Time